„Production of Lentivirus particles pseudotyped with SARS-CoV-2 spike protein for neutralisation or drug antiviral activity assays” (2023) One Health & Risk Management , p. 77. Disponibil la: https://journal.ohrm.bba.md/index.php/journal-ohrm-bba-md/article/view/657 (Data accesării: 22 iulie 2026).